Parents and experts are sounding the alarm about unregulated anabolic steroid use happening as a result of the pressure young men face to reach a certain ideal body type. Studies also suggest a ...
Overall survival at two years was 82.2% in the durvalumab group and 75.2% in the comparator group. Durvalumab (brand name Imfinzi) is a treatment for non small cell lung cancer (NSCLC) but is also ...